Cargando…
Targeting Antibiotic Resistance
Finding strategies against the development of antibiotic resistance is a major global challenge for the life sciences community and for public health. The past decades have seen a dramatic worldwide increase in human‐pathogenic bacteria that are resistant to one or multiple antibiotics. More and mor...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5071768/ https://www.ncbi.nlm.nih.gov/pubmed/27000559 http://dx.doi.org/10.1002/anie.201506818 |
_version_ | 1782461326080081920 |
---|---|
author | Chellat, Mathieu F. Raguž, Luka Riedl, Rainer |
author_facet | Chellat, Mathieu F. Raguž, Luka Riedl, Rainer |
author_sort | Chellat, Mathieu F. |
collection | PubMed |
description | Finding strategies against the development of antibiotic resistance is a major global challenge for the life sciences community and for public health. The past decades have seen a dramatic worldwide increase in human‐pathogenic bacteria that are resistant to one or multiple antibiotics. More and more infections caused by resistant microorganisms fail to respond to conventional treatment, and in some cases, even last‐resort antibiotics have lost their power. In addition, industry pipelines for the development of novel antibiotics have run dry over the past decades. A recent world health day by the World Health Organization titled “Combat drug resistance: no action today means no cure tomorrow” triggered an increase in research activity, and several promising strategies have been developed to restore treatment options against infections by resistant bacterial pathogens. |
format | Online Article Text |
id | pubmed-5071768 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-50717682016-11-02 Targeting Antibiotic Resistance Chellat, Mathieu F. Raguž, Luka Riedl, Rainer Angew Chem Int Ed Engl Reviews Finding strategies against the development of antibiotic resistance is a major global challenge for the life sciences community and for public health. The past decades have seen a dramatic worldwide increase in human‐pathogenic bacteria that are resistant to one or multiple antibiotics. More and more infections caused by resistant microorganisms fail to respond to conventional treatment, and in some cases, even last‐resort antibiotics have lost their power. In addition, industry pipelines for the development of novel antibiotics have run dry over the past decades. A recent world health day by the World Health Organization titled “Combat drug resistance: no action today means no cure tomorrow” triggered an increase in research activity, and several promising strategies have been developed to restore treatment options against infections by resistant bacterial pathogens. John Wiley and Sons Inc. 2016-03-22 2016-06-01 /pmc/articles/PMC5071768/ /pubmed/27000559 http://dx.doi.org/10.1002/anie.201506818 Text en © 2016 The Authors. Published by Wiley-VCH Verlag GmbH & Co. KGaA. This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial‐NoDerivs (http://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Reviews Chellat, Mathieu F. Raguž, Luka Riedl, Rainer Targeting Antibiotic Resistance |
title | Targeting Antibiotic Resistance |
title_full | Targeting Antibiotic Resistance |
title_fullStr | Targeting Antibiotic Resistance |
title_full_unstemmed | Targeting Antibiotic Resistance |
title_short | Targeting Antibiotic Resistance |
title_sort | targeting antibiotic resistance |
topic | Reviews |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5071768/ https://www.ncbi.nlm.nih.gov/pubmed/27000559 http://dx.doi.org/10.1002/anie.201506818 |
work_keys_str_mv | AT chellatmathieuf targetingantibioticresistance AT raguzluka targetingantibioticresistance AT riedlrainer targetingantibioticresistance |